Related Experiment Video
Updated: Jun 15, 2026
Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes
Published on: July 18, 2008
The Juvenile Parkinson's Disease Mutation C212Y Impairs Mitochondrial Homeostasis in a Caenorhabditis elegans Model
Eyal Spector1, Lirin Michaeli1, Anat Nitzan1
1Department of Cell and Developmental Biology, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Abstract:
Inherited Parkinson's disease (PD) often involves missense mutations in the PRKN2 gene, encoding for Parkin protein. The PDR-1 protein is the C. elegans ortholog of human Parkin. Using a CRISPR/Cas9 genome editing approach, we generated the PDR-1C169Y point mutation on a conserved cysteine residue in the RING0 domain. This mutation in human Parkin, C212Y, has been identified in autosomal recessive juvenile Parkinsonism patients. The PDR-1C169Y homozygous mutant animals exhibited a shorter lifespan and decreased thrashing rate compared with wild-type or heterozygous animals. Unique mitochondrial phenotypes were observed, including an increased mitochondrial area and mitochondrial membrane potential. However, these phenotypes did not activate the mitochondrial unfolded protein response. Pan-neuronal analysis revealed decreased mitophagy. Dopaminergic neurodegeneration in aged animals was not enhanced when compared to WT. Our findings suggest that analysis of the recessive missense point mutations found in early-onset PD using the C. elegans model system has the potential to advance our understanding of the molecular mechanisms that lead to neurodegeneration.
Insights
C. elegans PDR-1 mutations mimic human Parkinson's disease (PD) genetics. This study reveals mitochondrial dysfunction and reduced mitophagy, offering insights into early-onset PD mechanisms.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Inherited Parkinson's disease (PD) is linked to mutations in the PRKN2 gene, which encodes Parkin protein.
- The C. elegans PDR-1 protein is the ortholog of human Parkin.
- A specific mutation, C212Y in human Parkin, is found in patients with autosomal recessive juvenile Parkinsonism.
Purpose of the Study:
- To investigate the functional consequences of a conserved PDR-1 mutation (C169Y) in C. elegans.
- To model early-onset Parkinson's disease using genome editing.
- To understand the molecular mechanisms underlying neurodegeneration in Parkinson's disease.
Main Methods:
- CRISPR/Cas9 genome editing was used to introduce the PDR-1 C169Y point mutation in C. elegans.
- Homozygous and heterozygous mutant C. elegans were analyzed for lifespan, motor function (thrashing rate), and mitochondrial phenotypes.
- Pan-neuronal analysis was performed to assess mitophagy and dopaminergic neurodegeneration.
Main Results:
- Homozygous PDR-1 C169Y mutants showed reduced lifespan and decreased thrashing rates compared to wild-type.
- Unique mitochondrial alterations, including increased area and membrane potential, were observed.
- Despite mitochondrial changes, the mitochondrial unfolded protein response was not activated.
- Mitophagy was decreased in pan-neuronal analysis.
- No enhanced dopaminergic neurodegeneration was observed in aged mutant animals.
Conclusions:
- The PDR-1 C169Y mutation in C. elegans recapitulates aspects of human Parkinson's disease, including mitochondrial dysfunction and impaired mitophagy.
- This model system provides valuable insights into the molecular mechanisms of recessive, early-onset Parkinson's disease.
- Further studies using this model can advance understanding of neurodegenerative processes in Parkinson's disease.
